Clinical Trial Update: Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Olea Europaea Pollen [Phase 3]

View source ↗

Summary

Phase 3 trial update for subcutaneous immunotherapy targeting hypersensitivity to olive pollen (Olea europaea) in patients with rhinitis/rhinoconjunctivitis wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Rhinitis
• Rhinoconjunctivitis

Drugs mentioned

• subcutaneous immunotherapy treatment for Olea europaea pollen

Snippet

Sponsor: Laboratorios Leti, S.L. | Conditions: Rhinitis or Rhinoconjunctivitis With or Without Asthma Induced by Hypersensitivity to Olea Europea Pollen | Phase 3 | Status: COMPLETED